The Net Margin of Atrium Therapeutics Inc (RNA) is -265.88%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -265.88% |
| 2024-12-31 | -230.54% |
| 2023-12-31 | -65.39% |